Iranian Journal of Parasitology 2013. 8(4):516-521.

Seroprevalence of Human Fascioliasis in Meshkin-Shahr District, Ardabil Province, Northwestern Iran in 2012.
Samieh Asadian, Mehdi Mohebali, MahmodMAH Moudi, EshratBeigom Kia, Zahra Heidari, Majid Asgari, Mojgan Aryaeipour, SepidehMO Radi, Mohammad Bagher Rokni


Background: The aim of this study was to conduct a seroprevalence survey in Meshkin-Shahr, Ardabil Province, north western Iran to detect the rate of human fascioliasis in the city and nearby villages. Literature shows that no such study has been conducted so far.

Methods: Overall, 458 serum samples were collected by randomized cluster sam-pling method from 153 males and 305 females referred to different health centers of the region after recalling by staff in those centers in 2012. All cases filled out a questionnaire and an informed consent. Sera were analyzed using indirect-ELISA test. Ten μg /ml antigens (Liver Fluke Homogenate), serum dilutions of 1:500 and conjugate anti-human coombs with 1:10000 dilutions were utilized to perform the test. Data analysis was conducted using SPSS software ver. 18.

Results: Nine cases (1.96%) were positive for fascioliasis by ELISA test. The sero-prevalence of fascioliasis among females was 1.63% and 2.6% in males. There was no significant difference as regards age groups, sex, job, residency, literacy and con-suming row vegetable. According to job, unemployment subjects had the highest rate of infection as 5.9%. The seroprevalence of infection was 1.52% in illiterate people. As for residency, urban life showed no significant difference with rural life (2.4% vs. 1.42). Age group of 40-49 yr old, with 3.3% seropositivity had the highest rate.

Conclusion: Obtained seroprevalence of fascioliasis shows immediate attention of health authorities to the diseases in the area. The adjacent of Ardabil Province to endemic areas of fasciolosis accentuates this attention.


ELISA; Fasciolosis; Human; Iran; Seroprevalence

Full Text:



Mas-Coma S, Bargues M. Human liver flukes: A review. Res Rev Parasitol. 1997;57:145-218.

Mas-Coma S, Bargues MD, Valero MA. Fascioliasis and other plant-borne trematode zoonoses. Int J Parasitol. 2005;35:1255-1278.

Keiser J, Utzinger J. Emerging foodborne trematodiasis. Emerging Infectious Diseases. 2005;11:1507.

Fürst T, Keiser J, Utzinger J. Global burden of human food-borne trematodiasis: A systematic review and meta-analysis. The Lancet Infectious Diseases. 2012;12:210-221.

Massoud J. Fasciolosis outbreak in man and drug test (Triclabandazole) in caspian littoral, northern part of Iran. Bull Soc France Parasitol. 1989;8:438.

Assmar M, Milaninia A, Amir-Khani A, Yadegari D, Forghan-Parast K, Nahravanian H, Piazak N, Esmayli A, Hovanesian A, Valadkhani Z. Seroepidemiological investigation of fascioliasis in northern Iran.

Asadian et al.: Seroprevalence of Human Fascioliasis … 521

Medical Journal of the Islamic Republic of Iran. 1991;5:23-27.

Forghan-Parast K, Ashrafi K. Comparison of the formalin-ether and kato-katz in the parasitological diagnosis of human fascioliasis. J Med Fac Gilan Univ Med Sci Iran. 2001;9:1-6. [In Persian].

Rokni MB. The present status of human helminthic diseases in Iran. Ann Trop Med Parasitol. 2008;102:283-295.

Rokni MB, Massoud J, O'Neill SM, Parkinson M, Dalton JP. Diagnosis of human fasciolosis in the Gilan Province of northern Iran: Application of cathepsin L-ELISA. Diagn Microbiol Infect Dis. 2002;44:175-179.

Rokni MB. The present status of human helminthic diseases in Iran. Ann Trop Med Parasitol. 2008;102:283-295.

Mowlavi G, Mamishi S, Rokni M, Mobedi I, Gharaguzlo M, Ashrafi K, Mas-Coma S. Neglected human fascioliasis case in a visceral leishmaniasis endemic area, north-western Iran. Iranian J Publ Health. 2010;39:129-131.

Mohebali M, Hajjaran H, Hamzavi Y, Mobedi I, Arshi S, Zarei Z, Akhoundi B, Naeini KM, Avizeh R, Fakhar M. Epidemiological aspects of canine visceral leishmaniosis in the Islamic Republic of Iran. Vet Parasitol. 2005;129:243-251.

Ashrafi K, Saadat F, Rahmati B. Evaluating the level of endemicity of human fascioliasis in rural communities of Bandar-e-anzali district; an important step for implementation of disease control programs. First International and 8th National Congress of Parasitology and Parasitic Diseases in Iran. 2012:121

WHO. The" neglected" neglected worms. Action against worms. December 2007, issue 10. 2010

Mas-Coma S. Epidemiology of fascioliasis in human endemic areas. J Helminthol. 2005;-79:207-216.

Fuentes M, Valero M, Bargues M, Esteban J, Angles R, Mas-Coma S. Analysis of climatic data and forecast indices for human fascioliasis at very high altitude. Ann Trop Med Parasitol. 1999;93:835-850.

Moghaddam AS, Massoud J, Mahmoodi M, Mahvi AH, Periago MV, Artigas P, Fuentes MV, Bargues MD, Mas-Coma S. Human and animal fascioliasis in Mazandaran Province, northern Iran. Parasitol Res. 2004;94:61-69.

Lotfy WM, Hillyer GV. Fasciola species in Egypt. Exp Pathol Parasitol. 2003;6:9-22.

Soliman MF. Epidemiological review of human and animal fascioliasis in Egypt. The Journal of Infection in Developing Countries. 2008;2:182-189.

Zait H, Hamrioui B. [new cases of human fascioliasis in Algeria]. Medecine Tropicale: revue du Corps de sante colonial. 2005;65:395.

Qureshi AW, Tanveer A, WAHEED S, QURESHI A, GILL TJ, ALI SA. Epidemiology of human fasciolosis in rural areas of Lahore, Pakistan. Punjab Univ. J. Zool. 2005;20:159-168.

Farag H. Intestinal parasitosis in the population of the Yemen Arab republic. Trop Geog Med. 1985;37:29.

Sarkari B, Ghobakhloo N, Moshfea A, Eilami O. Seroprevalence of human fasciolosis in a new-emerging focus of fasciolosis in Yasuj District, southwest of Iran. Iranian J Parasitol. 2012;7:15-20.

Abdi J, Naserifar R, Rostami Nejad M, Mansouri V. New features of fascioliasis in human and animal infections in Ilam Province, western Iran. Gastroenterology and Hepato-logy from Bed to Bench. 2013;6:152-155.


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.